Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $122 | $119 | $180 | $189 |
| - Cash | $50 | $35 | $45 | $29 |
| + Debt | $236 | $238 | $231 | $223 |
| Enterprise Value | $309 | $322 | $365 | $383 |
| Revenue | $0 | $65 | $66 | $70 |
| % Growth | -99.3% | -1.1% | -6.4% | – |
| Gross Profit | $0 | $24 | $24 | $26 |
| % Margin | 36% | 36.3% | 36.4% | 36.7% |
| EBITDA | $0 | $10 | $11 | $12 |
| % Margin | 21.8% | 16% | 16.7% | 17.4% |
| Net Income | $0 | $3 | $4 | $8 |
| % Margin | 8.7% | 3.9% | 6.6% | 11.5% |
| EPS Diluted | 0.78 | 51.05 | 88.61 | 163.92 |
| % Growth | -98.5% | -42.4% | -45.9% | – |
| Operating Cash Flow | $0 | $6 | $18 | -$3 |
| Capital Expenditures | -$0 | -$4 | -$7 | -$10 |
| Free Cash Flow | -$0 | $2 | $11 | -$13 |